Tunisian Multicenter Study on the Prevalence of Colistin Resistance in Clinical Isolates of Gram Negative Bacilli: Emergence of
Gram negative bacteria
colistin resistance
mcr-1 gene
multi-drug resistant bacteria
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
11 Oct 2022
11 Oct 2022
Historique:
received:
19
08
2022
revised:
12
09
2022
accepted:
02
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
Actually, no data on the prevalence of plasmid colistin resistance in Tunisia are available among clinical bacteria. This study aimed to investigate the current epidemiology of colistin resistance and the spread of the A total of 836 GNB strains were inoculated on COL-R agar plates with selective screening agar for the isolation of GNB resistant to colistin. For the selected isolates, Colistin-resistance was detected in 5.02% (42/836) of the isolates and colistin-resistant isolates harboured an ESBL ( This study reports the first description of the
Sections du résumé
BACKGROUND
BACKGROUND
Actually, no data on the prevalence of plasmid colistin resistance in Tunisia are available among clinical bacteria.
OBJECTIVES
OBJECTIVE
This study aimed to investigate the current epidemiology of colistin resistance and the spread of the
METHODS
METHODS
A total of 836 GNB strains were inoculated on COL-R agar plates with selective screening agar for the isolation of GNB resistant to colistin. For the selected isolates,
RESULTS
RESULTS
Colistin-resistance was detected in 5.02% (42/836) of the isolates and colistin-resistant isolates harboured an ESBL (
THE CONCLUSIONS
CONCLUSIONS
This study reports the first description of the
Identifiants
pubmed: 36290048
pii: antibiotics11101390
doi: 10.3390/antibiotics11101390
pmc: PMC9598684
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Microbiol Methods. 2005 Dec;63(3):219-28
pubmed: 15935499
Int J Antimicrob Agents. 2018 Dec;52(6):861-865
pubmed: 30176353
J Antimicrob Chemother. 2016 Aug;71(8):2340-2
pubmed: 27246233
Environ Microbiol Rep. 2013 Feb;5(1):58-65
pubmed: 23757131
J Glob Antimicrob Resist. 2019 Dec;19:280-283
pubmed: 31100503
Comp Immunol Microbiol Infect Dis. 2019 Dec;67:101366
pubmed: 31627036
Int J Antimicrob Agents. 2016 Jan;47(1):4-5
pubmed: 26724188
Euro Surveill. 2018 Feb;23(6):
pubmed: 29439754
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6996-6997
pubmed: 27572400
Int J Food Microbiol. 2018 Mar 23;269:60-63
pubmed: 29421359
Lancet Infect Dis. 2016 Feb;16(2):161-8
pubmed: 26603172
Antimicrob Agents Chemother. 2000 Jun;44(6):1568-74
pubmed: 10817710
Front Microbiol. 2020 Feb 04;11:80
pubmed: 32117115
J Antimicrob Chemother. 2010 Mar;65(3):490-5
pubmed: 20071363
Diagn Microbiol Infect Dis. 2011 May;70(1):119-23
pubmed: 21398074
J Glob Antimicrob Resist. 2020 Sep;22:538-545
pubmed: 32251867
Int J Antimicrob Agents. 2016 Dec;48(6):581-582
pubmed: 27939183
Antimicrob Agents Chemother. 2018 Jan 25;62(2):
pubmed: 29229634
J Glob Antimicrob Resist. 2017 Sep;10:88-94
pubmed: 28711559